SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1745-1756
Author(s):
A. Y. Tsygankov and S. K. Shore
Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1767-1784
Author(s):
M. Cetkovic-Cvrlje and H. E. Tibbles
Gene Therapy for Heart Transplantation-Associated Acute Rejection, Ischemia / Reperfusion Injury and Coronary Arteriosclerosis
Journal:
Current Gene Therapy
Volume:
4
Page:
145-152
Author(s):
Mitsuaki Isobe, Hisanori Kosuge, Noritaka Koga, Hideki Futamatsu and Jun-ichi Suzuki
Clinical Use of Intracoronary Gene Transfer of Fibroblast Growth Factor for Coronary Artery Disease
Journal:
Current Gene Therapy
Volume:
4
Page:
225-230
Author(s):
W. F. Penny and H. Kirk Hammond
Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
327-336
Author(s):
Daniel Sliva
Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
345-354
Author(s):
Jian Yu Rao and Ning Li
The Design of Drug Candidate Molecules as Selective Inhibitors of Therapeutically Relevant Protein Kinases
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
1563-1583
Author(s):
P. M. Fischer
Chemokine Receptor-directed Agents as Novel Anti-HIV-1 Therapies
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1017-1033
Author(s):
Sander G. Mills and Julie A. DeMartino
Ubiquitin-Protein Ligases - Novel Therapeutic Targets?
Journal:
Current Protein & Peptide Science
Volume:
5
Page:
163-176
Author(s):
Philip A. Robinson and Helen C. Ardley
Ferroquine: A New Weapon in the Fight Against Malaria
Journal:
Current Medicinal Chemistry - Anti-Infective Agents
Volume:
3
Page:
135-147
Author(s):
Christophe Biot